Novel function of E26 transformation-specific domain-containing protein ELK3 in lymphatic endothelial cells

Ji In Park, Kwang Soo Kim, Sun Young Kong, Kyung Soon Park*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Lymphatic endothelial cells (LEC) are major components of the tumor microenvironment and, due to the relative leakiness of lymphatic vessels compared with blood vessels, are essential for tumor dissemination and metastasis. In the present study, small interfering RNA-mediated suppression of E26 transformation-specific domain-containing protein Elk-3 (ELK3) inhibited the proliferation, migration and tube-forming ability of LEC. Suppression of ELK3 decreased vascular endothelial-cadherin expression levels and increased the phosphorylation of β-catenin. Furthermore, vascular endothelial growth factor receptor-3 (VEGFR-3) mRNA and protein expression levels were suppressed by the transfection of LEC with siELK3. As VEGFR-3 serves a major role in lymphangiogenesis, ELK3 may be a novel therapeutic target to inhibit tumor dissemination through the lymphatic system.

Original languageEnglish (US)
Pages (from-to)55-60
Number of pages6
JournalOncology Letters
Volume15
Issue number1
DOIs
StatePublished - Jan 2018

Funding

The present study was supported by the Korea Science and Engineering Foundation of the Korean government (grant no. 2015R1A2A2A01003498). Ministry of Education, Science, and Technology (NRF-2017-M3A9B4031169).

Keywords

  • E26 transformation-specific domain-containing protein Elk‑3
  • Lymphatic endothelial cell
  • Migration
  • Proliferation
  • Vascular endothelial growth factor receptor‑3

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Novel function of E26 transformation-specific domain-containing protein ELK3 in lymphatic endothelial cells'. Together they form a unique fingerprint.

Cite this